Eloxx Pharmaceuticals ELOX
NASDAQ ELOX
$13.01 +0.11 (+0.85%)
At close: Nov 11, 2026 · 4:00 PM EST

Eloxx Pharmaceuticals (ELOX) Receivables (2009 - 2014)

Updated

Eloxx Pharmaceuticals' Receivables came in at $203,915 for Q2 2015, up 372.8% from the prior quarter.

Analysis

Eloxx Pharmaceuticals (ELOX) Receivables (2009 - 2014) Analysis & Trends

At the end of FY2014, Eloxx Pharmaceuticals' Receivables was $43,133.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 25.23 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 18.99 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 13.51 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 12.74 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 16.16 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 10.35 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 5.01 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 14.19 Bn
10 Eloxx Pharmaceuticals 87.58 Mn 13.90 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2014 203,915.00
Sep 30, 2014 43,133.00
Jun 30, 2014 43,133.00
Dec 31, 2009 140,000.00
Sep 30, 2009 392,000.00
API Access

Eloxx Pharmaceuticals Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=ELOX&period=max&api_key=YOUR_API_KEY